Cargando…

Intrapericardial bevacizumab safely and effectively treats malignant pericardial effusion in advanced cancer patients

We evaluated the safety and efficacy of intrapericardial bevacizumab (BEV) for treating symptomatic malignant pericardiac effusion (MPCE) in seven advanced cancer patients. All patients had previously undergone multiple lines of systemic therapy. Each patient received paracentesis and intrapericardi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Dawei, Zhang, Yan, Shi, Fang, Zhu, Hui, Li, Minghuan, Chen, Kaijun, Kong, Li, Yu, Jinming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Clinical Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5239564/ https://www.ncbi.nlm.nih.gov/pubmed/27203219 http://dx.doi.org/10.18632/oncotarget.9420

Ejemplares similares

Sustained response of malignant pericardial effusion to intrapericardial bevacizumab in an advanced lung cancer patient: a case report and literature review
por: Chen, Dawei, et al.
Publicado: (2015)

A randomised trial of intrapericardial bleomycin for malignant pericardial effusion with lung cancer (JCOG9811)
por: Kunitoh, H, et al.
Publicado: (2009)

Voluminous Intrapericardial Lipoma Mimicking Pericardial Effusion
por: Prado de Morais, Fabíola, et al.
Publicado: (2020)

Unusual intrapericardial pressure pattern in localized pericardial effusion
por: Yalonetsky, Sergey, et al.
Publicado: (2020)

Intrapericardial carboplatin in the management of malignant pericardial effusion in breast cancer: a pilot study
por: Kotake, Mie, et al.
Publicado: (2019)

Intrapericardial Doppler Flow Signals in a Patient with Postsurgical Pericardial Effusion
por: Mancuso, Luigi, et al.
Publicado: (2017)

Controlling malignant pericardial effusion by intrapericardial carboplatin administration in patients with primaryon-small-cell lung cancer
por: Moriya, T, et al.
Publicado: (2000)

Management of Lung Cancer-Associated Malignant Pericardial Effusion with Intrapericardial Administration of Carboplatin: A Retrospective Study
por: Imai, Hisao, et al.
Publicado: (2021)

Efficacy of Intrapleural or Intrapericardial Injection of Single Bevacizumab in the Treatment of Lung Cancer-Mediated Malignant Effusion
por: He, Dongyun, et al.
Publicado: (2022)

Greater efficacy of intracavitary infusion of bevacizumab compared to traditional local treatments for patients with malignant cavity serous effusion
por: Chen, Dawei, et al.
Publicado: (2016)

Prolonged Drainage and Intrapericardial Bleomycin Administration for Cardiac Tamponade Secondary to Cancer-Related Pericardial Effusion
por: Numico, Gianmauro, et al.
Publicado: (2016)

The efficacy and safety of complete pericardial drainage by means of intrapericardial fibrinolysis for the prevention of complications of pericardial effusion: a systematic review protocol
por: Kakia, Aloysious, et al.
Publicado: (2016)

Effects of intrapericardial administration after catheter drainage on malignant pericardial effusion in non‐small cell lung cancer: A real‐world study
por: Wei, Jingwen, et al.
Publicado: (2023)

Pericardial Window Formation Complicated by Intrapericardial Diaphragmatic Hernia
por: Docekal, Jeremy, et al.
Publicado: (2014)

Advanced lung cancer presenting with malignant pericardial effusion
por: Sadiq, Abid M., et al.
Publicado: (2021)

Management of Malignant Pericardial Effusion
por: Petrofsky, Mary
Publicado: (2014)

The Efficacy, Safety, and Side Effects of Intrapericardial Triamcinolone Treatment in Children with Post-surgical Pericardial Effusion: A Case Series
por: van der Werff, Manon H., et al.
Publicado: (2021)

Bevacizumab helped resolve pericardial and pleural effusion that was associated with malignant ovarian clear cell carcinoma
por: Ueda, Tomoko, et al.
Publicado: (2016)

Cytokines in Pericardial Effusion of Patients with Inflammatory Pericardial Disease
por: Karatolios, Konstantinos, et al.
Publicado: (2012)

The Prognostic Impact of Pericardial Fluid Cytology in Malignant Pericardial Effusion
por: Sezenöz, Burak, et al.
Publicado: (2023)

Intrapericardial Thymoma Presented as Pericardial Tamponade with Post-Operative Myasthenia Gravis
por: Tsai, Yueh-Hsun, et al.
Publicado: (2022)

Massive pericardial effusion caused by hypothyroidism
por: Schmitt, Willian, et al.
Publicado: (2018)

Pericardial effusion uncovering underlying hypothyroidism
por: Ponnapalli, Anoosha, et al.
Publicado: (2021)

Pericardial Effusion of Obscure Origin
por: Muralimohan, Ramya, et al.
Publicado: (2014)

Malignant pericardial effusion: sclerotherapy or local chemotherapy?
por: Lestuzzi, C, et al.
Publicado: (2009)

Survival post surgery for malignant pericardial effusion
por: Nguyen, Olivier, et al.
Publicado: (2011)

A case series of malignant pericardial effusion
por: Babu, Reshma S., et al.
Publicado: (2022)

Systemic sclerosis with renal crisis and pericardial effusion
por: Prudhvi, Kalyan, et al.
Publicado: (2020)

Pericardial effusion
por: Marchiori, Edson, et al.
Publicado: (2021)

Water bottle sign of pericardial effusion on chest radiograph
por: Xien, Yee Li, et al.
Publicado: (2020)

Treatment of malignant pericardial effusion with (32)P-colloid
por: Dempke, W, et al.
Publicado: (1999)

Antibody-guided irradiation of malignant pleural and pericardial effusions.
por: Pectasides, D., et al.
Publicado: (1986)

Prognostic relevance of pericardial effusion in patients with malignant diseases
por: Jeong, Tae-Dong, et al.
Publicado: (2012)

Reply to ‘Malignant pericardial effusion: sclerotherapy or local chemotherapy?’
por: Kunitoh, H, et al.
Publicado: (2009)

Serum BNP levels are associated with malignant pericardial effusion
por: Carasso, Shemy, et al.
Publicado: (2019)

Lung Adenocarcinoma Presenting as Malignant Pericardial Effusion/Tamponade
por: Vemireddy, Lalitha Padmanabha, et al.
Publicado: (2021)

Outcomes of Patients with and without Malignancy Undergoing Percutaneous Pericardiocentesis for Pericardial Effusion
por: Shih, Chun-Ting, et al.
Publicado: (2021)

Curative Effects of Dendritic Cells Combined with Cytokine-Induced Killer Cells in Patients with Malignant Pericardial Effusion
por: Wang, Hongmin, et al.
Publicado: (2016)

Better efficacy of intrapleural infusion of bevacizumab with pemetrexed for malignant pleural effusion mediated from nonsquamous non-small cell lung cancer
por: Song, Xinyu, et al.
Publicado: (2018)

Addition of bevacizumab for malignant pleural effusion as the manifestation of acquired EGFR-TKI resistance in NSCLC patients
por: Jiang, Tao, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_3c7gok2ja7f80o1cnrh05hlvun